新的和积极的血压目标治疗高血压

Q4 Medicine Open Hypertension Journal Pub Date : 2020-01-01 DOI:10.15713/ins.johtn.0188
P. Sanzgiri, K. Reddy
{"title":"新的和积极的血压目标治疗高血压","authors":"P. Sanzgiri, K. Reddy","doi":"10.15713/ins.johtn.0188","DOIUrl":null,"url":null,"abstract":"The benefits of blood pressure (BP) lowering treatment for the prevention of cardiovascular disease are well established. However, aggressive control of BP is controversial, as it leads to a reduction in organ perfusion and function, thereby increasing overall morbidity and mortality. An elusive balance is now being sought between deleterious effects of hypotension and protective autoregulatory mechanism. Here, we perform a systematic review of data and the current status of aggressive control of BP in various clinical settings.","PeriodicalId":38918,"journal":{"name":"Open Hypertension Journal","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Newer and Aggressive Blood Pressure Goals to Treat Hypertension\",\"authors\":\"P. Sanzgiri, K. Reddy\",\"doi\":\"10.15713/ins.johtn.0188\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The benefits of blood pressure (BP) lowering treatment for the prevention of cardiovascular disease are well established. However, aggressive control of BP is controversial, as it leads to a reduction in organ perfusion and function, thereby increasing overall morbidity and mortality. An elusive balance is now being sought between deleterious effects of hypotension and protective autoregulatory mechanism. Here, we perform a systematic review of data and the current status of aggressive control of BP in various clinical settings.\",\"PeriodicalId\":38918,\"journal\":{\"name\":\"Open Hypertension Journal\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Hypertension Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15713/ins.johtn.0188\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Hypertension Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15713/ins.johtn.0188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

降压治疗对预防心血管疾病的益处已得到充分证实。然而,积极控制血压是有争议的,因为它会导致器官灌注和功能的减少,从而增加总体发病率和死亡率。在低血压的有害作用和保护性的自我调节机制之间,目前正在寻求一种难以捉摸的平衡。在这里,我们对各种临床环境下积极控制血压的数据和现状进行了系统的回顾。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Newer and Aggressive Blood Pressure Goals to Treat Hypertension
The benefits of blood pressure (BP) lowering treatment for the prevention of cardiovascular disease are well established. However, aggressive control of BP is controversial, as it leads to a reduction in organ perfusion and function, thereby increasing overall morbidity and mortality. An elusive balance is now being sought between deleterious effects of hypotension and protective autoregulatory mechanism. Here, we perform a systematic review of data and the current status of aggressive control of BP in various clinical settings.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Open Hypertension Journal
Open Hypertension Journal Medicine-Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
期刊最新文献
Implementation of a Resistant Hypertension Control Program in a Low-income Primary Care Setting in a High-Income Country: Lessons Learned and Global Applicability Troponin and B-type Natriuretic Peptides Biomarkers in the Management of Hypertension Hypertension in end-stage kidney disease Confirming a Diagnosis of "Hypertension" Sodium-glucose Co-transporter 2 Inhibitors and Blood Pressure Reduction among Patients with Diabetes, Cardiovascular Disease, Chronic Kidney Disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1